380 related articles for article (PubMed ID: 23499587)
1. Relationship between the distribution of plasma HDL subclasses and the polymorphisms of APOA5 in hypertriglyceridemia.
Long S; Chen Z; Han Y; Christopher DM; Zhang C; Yang Y; Tian Y
Clin Biochem; 2013 Jun; 46(9):733-9. PubMed ID: 23499587
[TBL] [Abstract][Full Text] [Related]
2. APOA5-1131T>C genotype effects on apolipoprotein A5 and triglyceride levels in response to dietary intervention and regular exercise (DIRE) in hypertriglyceridemic subjects.
Jang Y; Chae JS; Kim OY; Park HJ; Kim JY; Paik JK; Lee SH; Lee JH
Atherosclerosis; 2010 Aug; 211(2):512-9. PubMed ID: 20392444
[TBL] [Abstract][Full Text] [Related]
3. Association of apolipoprotein A-V concentration with apolipoprotein A5 gene -1131T>C polymorphism and fasting triglyceride levels.
Kim JY; Kim OY; Paik JK; Lee SH; Lee JH
J Clin Lipidol; 2013; 7(2):94-101. PubMed ID: 23415427
[TBL] [Abstract][Full Text] [Related]
4. Association of apolipoprotein A5 gene polymorphisms and serum lipid levels.
Li YY; Yin RX; Lai CQ; Li M; Long XJ; Li KL; Liu WY; Zhang L; Wu JZ
Nutr Metab Cardiovasc Dis; 2011 Dec; 21(12):947-56. PubMed ID: 20708914
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein A5 and apolipoprotein C3 single nucleotide polymorphisms are correlated with an increased risk of coronary heart disease: a case-control and meta-analysis study.
Yang G; Lei MM; Yu CL; Liu XX; An Z; Song CL
Lipids Health Dis; 2015 Sep; 14():113. PubMed ID: 26387083
[TBL] [Abstract][Full Text] [Related]
6. Plasma apoAV levels are markedly elevated in severe hypertriglyceridemia and positively correlated with the APOA5 S19W polymorphism.
Henneman P; Schaap FG; Havekes LM; Rensen PC; Frants RR; van Tol A; Hattori H; Smelt AH; van Dijk KW
Atherosclerosis; 2007 Jul; 193(1):129-34. PubMed ID: 16777114
[TBL] [Abstract][Full Text] [Related]
7. Interaction between APOA5 -1131T>C and APOE polymorphisms and their association with severe hypertriglyceridemia.
Sousa MO; Alía P; Pintó X; Corbella E; Navarro MA
Clin Chim Acta; 2008 Sep; 395(1-2):68-71. PubMed ID: 18549811
[TBL] [Abstract][Full Text] [Related]
8. Association of APOA5 and APOC3 gene polymorphisms with plasma apolipoprotein A5 level in patients with metabolic syndrome.
Niculescu LS; Vlădică M; Sima AV
Biochem Biophys Res Commun; 2010 Jan; 391(1):587-91. PubMed ID: 19932084
[TBL] [Abstract][Full Text] [Related]
9. Strong linkage disequilibrium and association of -1131T>C and c.553G>T polymorphisms of the apolipoprotein A5 gene with hypertriglyceridemia in a Japanese population.
Matsunaga A; Arishima H; Niimura H; Zhang B; Uehara Y; Ohwaki K; Morita M; Hayashida K; Saku K
Circ J; 2007 May; 71(5):746-52. PubMed ID: 17457003
[TBL] [Abstract][Full Text] [Related]
10. A promoter variant of the APOA5 gene increases atherogenic LDL levels and arterial stiffness in hypertriglyceridemic patients.
Kim M; Kim M; Yoo HJ; Lee E; Chae JS; Lee SH; Lee JH
PLoS One; 2017; 12(12):e0186693. PubMed ID: 29211729
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein A5 gene promoter region-1131T/C polymorphism is associated with risk of ischemic stroke and elevated triglyceride levels: a meta-analysis.
Pi Y; Zhang L; Yang Q; Li B; Guo L; Fang C; Gao C; Wang J; Xiang J; Li J
Cerebrovasc Dis; 2012; 33(6):558-65. PubMed ID: 22688093
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein A1/C3/A5 haplotypes and serum lipid levels.
Yin RX; Li YY; Lai CQ
Lipids Health Dis; 2011 Aug; 10():140. PubMed ID: 21854571
[TBL] [Abstract][Full Text] [Related]
13. Association of APOA5 c.553G>T polymorphism with type 2 diabetes mellitus in a Chinese population.
Zhai G; Wen P; Guo L; Chen L
Clin Chem Lab Med; 2006; 44(11):1313-6. PubMed ID: 17087641
[TBL] [Abstract][Full Text] [Related]
14. The apolipoprotein A5 -1131T>C promoter polymorphism in Koreans: association with plasma APOA5 and serum triglyceride concentrations, LDL particle size and coronary artery disease.
Jang Y; Paik JK; Hyun YJ; Chae JS; Kim JY; Choi JR; Lee SH; Shin DJ; Ordovas JM; Lee JH
Clin Chim Acta; 2009 Apr; 402(1-2):83-7. PubMed ID: 19159622
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein A5 T-1131C variant and risk for metabolic syndrome in obese adolescents.
Zaki M; Amr K
Gene; 2014 Jan; 534(1):44-7. PubMed ID: 24161374
[TBL] [Abstract][Full Text] [Related]
16. Relationship between plasma HDL subclasses distribution and lipoprotein lipase gene HindIII polymorphism in hyperlipidemia.
Long S; Tian Y; Zhang R; Yang L; Xu Y; Jia L; Fu M
Clin Chim Acta; 2006 Apr; 366(1-2):316-21. PubMed ID: 16364275
[TBL] [Abstract][Full Text] [Related]
17. Association of APOA5 -1131T>C polymorphism and serum lipid levels in patients with type 2 diabetes.
Celap I; Simundic AM; Nikolac N; Kackov S; Katalinic D
DNA Cell Biol; 2013 Oct; 32(10):589-93. PubMed ID: 23919616
[TBL] [Abstract][Full Text] [Related]
18. Gender-modulated impact of apolipoprotein A5 gene (APOA5) -1131T>C and c.56C>G polymorphisms on lipids, dyslipidemia and metabolic syndrome in Turkish adults.
Komurcu-Bayrak E; Onat A; Poda M; Humphries SE; Palmen J; Guclu F; Can G; Erginel-Unaltuna N
Clin Chem Lab Med; 2008; 46(6):778-84. PubMed ID: 18601598
[TBL] [Abstract][Full Text] [Related]
19. Increased risk of obesity related to total energy intake with the APOA5-1131T > C polymorphism in Korean premenopausal women.
Lim HH; Choi M; Kim JY; Lee JH; Kim OY
Nutr Res; 2014 Oct; 34(10):827-36. PubMed ID: 25263629
[TBL] [Abstract][Full Text] [Related]
20. Relationship between plasma lipid concentrations and HDL subclasses.
Yang Y; Yan B; Fu M; Xu Y; Tian Y
Clin Chim Acta; 2005 Apr; 354(1-2):49-58. PubMed ID: 15748599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
